Northeast Pharmaceutical Group Co Ltd (000597) — Capital Reinvestment Ratio
Northeast Pharmaceutical Group Co Ltd (000597) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥274.09 Million) in capital expenditures (CN¥11.48 Million). See how leveraged is Northeast Pharmaceutical Group Co Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Northeast Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (1999–2025)
This chart tracks Northeast Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check Northeast Pharmaceutical Group Co Ltd (000597) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year Capital Reinvestment Ratio for Northeast Pharmaceutical Group Co Ltd from 1999 to 2025. For live market cap and broader valuation context, see market value of Northeast Pharmaceutical Group Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥1.11 Billion | CN¥97.78 Million | ▼ -57.9% |
| 2024 | 0.21x | CN¥758.76 Million | CN¥159.43 Million | ▼ -47.6% |
| 2023 | 0.40x | CN¥586.75 Million | CN¥235.43 Million | ▲ +82.2% |
| 2022 | 0.22x | CN¥1.11 Billion | CN¥244.13 Million | ▲ +37.2% |
| 2021 | 0.16x | CN¥746.51 Million | CN¥119.81 Million | ▼ -77.1% |
| 2020 | 0.70x | CN¥570.92 Million | CN¥400.38 Million | ▲ +7.9% |
| 2019 | 0.65x | CN¥352.60 Million | CN¥229.17 Million | ▼ -67.2% |
| 2018 | 1.98x | CN¥285.09 Million | CN¥565.74 Million | ▲ +331.1% |
| 2016 | 0.46x | CN¥384.51 Million | CN¥177.01 Million | ▼ -86.7% |
| 2015 | 3.47x | CN¥99.70 Million | CN¥346.04 Million | ▼ -69.4% |
| 2014 | 11.33x | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥54.62 Million | CN¥9.41 Million | — |